Total planned funding: $156,299,493
Allocations
Countries/Regions
India | $156,299,493 |
Organizational Types
Unknown | $66,315,998 |
NGO | $45,598,060 |
Own Agency | $22,987,551 |
University | $13,832,112 |
Private Contractor | $2,589,272 |
Multi-lateral Agency | $2,010,000 |
FBO | $1,400,000 |
Host Country Government Agency | $939,200 |
Other USG Agency | $627,300 |
Implementing Agency | $0 |
Program Areas
Governance and Systems | $52,089,643 |
Prevention | $43,261,570 |
Care | $25,980,914 |
Management and Operations | $17,386,908 |
Testing | $9,820,977 |
Treatment | $7,759,481 |
Budget Codes
OHSS: Health Systems Strengthening | $29,153,353 |
HVOP: Sexual Prevention: Other Sexual Prevention | $23,982,274 |
HVSI: Strategic Information | $18,305,442 |
HVMS: Management and Operations | $17,386,908 |
HBHC: Care: Adult Care and Support | $17,036,351 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $11,232,190 |
HVCT: Testing: HIV Testing and Counseling | $9,820,977 |
HTXS: Treatment: Adult Treatment | $7,312,846 |
HKID: Care: Orphans and Vulnerable Children | $4,769,601 |
HLAB: Laboratory Infrastructure | $4,630,848 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,673,057 |
HVTB: Care: TB/HIV | $3,421,622 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,064,396 |
HMBL: Biomedical Prevention: Blood Safety | $1,299,653 |
PDCS: Care: Pediatric Care and Support | $753,340 |
PDTX: Treatment: Pediatric Treatment | $423,158 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $10,000 |
Top Partner Programs
Not Available:
$65,691,509
Countries/Regions
USG Aggregated Agencies:
$12,419,484
Countries/Regions
Voluntary Health Services:
$11,360,000
Countries/Regions
FHI 360:
$9,014,825
Countries/Regions